Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1291, 2001-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Oxybutynin ER better value than tolterodine IR for overactive bladder
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 447, 2004-01 ,pp. :
By Guest J.F. Abegunde D. Ruiz F.J.
Clinical Drug Investigation, Vol. 24, Iss. 6, 2004-01 ,pp. :
Transdermal Oxybutynin: For Overactive Bladder
By Bang L.M. Easthope S.E. Perry C.M.
Drugs & Aging, Vol. 20, Iss. 11, 2003-01 ,pp. :
Tolterodine for the treatment of overactive bladder: a review
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 4, 2005-04 ,pp. :